Capital goods treatment for plant air-conditioners used to maintain pharmaceutical manufacturing conditions and support Modvat credit.

Air-conditioners installed inside a pharmaceutical manufacturing plant to maintain the sanitised environment required for production were treated as capital goods under Rule 57Q. The equipment was used in the manufacturing area, not office premises, and had a direct nexus with product quality because environmental control was necessary under the Drugs Control Order. The Tribunal followed the Larger Bench ruling on environmental control equipment and its own earlier decision recognising plant-based air-conditioners for the relevant period, and Modvat credit was allowed.

---

---

Issues: Whether air-conditioners used in the manufacturing plant to maintain the requisite environment for pharmaceutical production qualify as capital goods eligible for Modvat credit under Rule 57Q of the Central Excise Rules, 1944.

Analysis: The air-conditioners were installed in the plant, not in office premises, and were used only to control the environment in the area where pharmaceuticals were manufactured. A sanitised environment was required under the Drugs Control Order, and such environmental control had a direct nexus with the quality of the final product. The issue was covered by the Larger Bench decision on environmental control equipment and by the Tribunal's decision allowing air-conditioners used in the plant for the relevant period.

Conclusion: The air-conditioners were held to be eligible capital goods and Modvat credit was allowable; the Revenue's appeal failed.

---